NASDAQ
28.08.26 | 22:00
14,300 US-Dollar
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | BrainsWay Deep TMS Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation | 2 | GlobeNewswire (USA) | ||
| Do | Brainsway Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 13.08. | BrainsWay übertrifft Umsatzprognosen in Q2 2026 und hebt Ausblick an | 2 | Investing.com Deutsch | ||
| 12.08. | BrainsWay's valuation has jumped 20-fold as its brain disorder treatment business takes off | 2 | CTech | ||
| 12.08. | Brainsway stock price target raised to $20 by BTIG on revenue beat | 2 | Investing.com | ||
| 12.08. | BTIG hebt Kursziel für Brainsway nach Umsatzplus auf 20 US-Dollar an | 2 | Investing.com Deutsch | ||
| BRAINSWAY Aktie jetzt für 0€ handeln | |||||
| 12.08. | BrainsWay Ltd. Q2 Profit Advances | 4 | RTTNews | ||
| 12.08. | BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights | 751 | GlobeNewswire (Europe) | Record second quarter 2026 revenue increased 35% to $17.1 million, compared with Q2 2025 Adjusted EBITDA more than doubled year-over-year to $3.5 million, with margin expanding to 20% Remaining... ► Artikel lesen | |
| 12.08. | Brainsway Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 11.08. | BrainsWay Q2 2026 Earnings Preview | 1 | Seeking Alpha | ||
| 29.07. | BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026 | 3 | GlobeNewswire (USA) | ||
| 24.07. | H.C. Wainwright bestätigt Kaufempfehlung für Brainsway nach strategischen Investitionen | 1 | Investing.com Deutsch | ||
| 24.07. | H.C. Wainwright reiterates Brainsway stock rating on strategic investments | 2 | Investing.com | ||
| 20.07. | BrainsWay makes $3M minority investment in Radial Health | 1 | Seeking Alpha | ||
| 20.07. | BrainsWay beteiligt sich mit 3 Millionen US-Dollar an Radial Health | 1 | Investing.com Deutsch | ||
| 20.07. | BrainsWay invests $3 million in Radial Health network | 3 | Investing.com | ||
| 20.07. | BrainsWay Announces Strategic Investment in Radial Health, Inc. | 1.014 | GlobeNewswire (Europe) | BURLINGTON, Mass. and JERUSALEM, July 20, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies... ► Artikel lesen | |
| 20.07. | BTIG initiates Brainsway stock with buy rating on TMS growth outlook | 4 | Investing.com | ||
| 17.07. | Brainsway stock rating reiterated at Buy by H.C. Wainwright | 1 | Investing.com | ||
| 17.07. | Brainsway stock price target reiterated at $14 by H.C. Wainwright | 2 | Investing.com |
1 2 3 4 Weiter >>
74 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,672 | +1,18 % | BetterHelp Has the Demand: Can Teladoc Build the Capacity? | ||
| ATOSSA THERAPEUTICS | 2,240 | 0,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| BUTTERFLY NETWORK | 7,378 | +1,33 % | Michael Burry sagt nur: wow: Butterfly +56 %: Die kleine Aktie hinter Midjourneys 60-Sekunden-Körperscanner | © Foto: Jaque Silva - NurPhotoMidjourney plant einen 60-Sekunden-Körperscanner per Ultraschall und KI. Butterfly liefert die Technik für den Prototyp. Anleger haben die Aktie am Donnerstag brutal hochgekauft... ► Artikel lesen | |
| BEYOND AIR | 4,350 | -2,90 % | Morning Market Movers: Vistance Networks, Beyond Air, Elastic N.V., Key Tronic See Big Swings | OTTAWA (dpa-AFX) - At 8:10 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AETHLON MEDICAL | 2,480 | -0,40 % | Aethlon Medical, Inc.: Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier Program | Conference Call Today at 4:30 p.m. ET
SAN DIEGO, Aug. 13, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a clinical-stage medical... ► Artikel lesen | |
| AVANOS MEDICAL | 21,600 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 27.07.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 27.07.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 27.07.2026.ISIN NameCA05335P1099 AUXLY... ► Artikel lesen | |
| ANGIODYNAMICS | 13,600 | +0,74 % | Biotech Stocks At 52-Week Highs - Cumberland Pharmaceuticals, Maravai LifeSciences, AngioDynamics, Acadia Healthcare, Teladoc Health | BENTONVILLE (dpa-AFX) - The following biotech stocks reached a 52-week high on July 15, 2026, driven by catalysts such as recent business developments or positive quarterly reports.Cumberland... ► Artikel lesen | |
| APYX MEDICAL | 2,500 | -2,34 % | Apyx Medical Corporation Reports Second Quarter 2026 Financial Results | Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segmentSuccessful limited launch of the power liposuction handpiece... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 8,735 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Change of Director's Interest Notice | ||
| ADAPTHEALTH | 5,800 | +0,17 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AVITA MEDICAL | 8,750 | -2,78 % | AVITA Medical, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| AUTONOMIX MEDICAL | 5,285 | -0,66 % | Autonomix Medical, Inc. - 8-K, Current Report | ||
| BLUEJAY DIAGNOSTICS | 0,890 | -1,11 % | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony IL-6 Toward Regulatory Submission and Commercialization | SYMON-II pivotal clinical study completes targeted enrollment of 750 patientsCompany advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate... ► Artikel lesen | |
| AGAPE ATP | 2,430 | 0,00 % | Morning Market Movers: Intercont (Cayman), Agape ATP, Astrotech, Snowflake See Big Swings | TOKYO (dpa-AFX) - At 8:05 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BONE BIOLOGICS | 0,596 | -3,04 % | BONE BIOLOGICS CORPORATION: Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities | BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) ("Bone Biologics" or the "Company"), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen |
BRAINSWAY LTD ADR gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 14,300 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRAINSWAY LTD ADR finden Sie auf Wallstreet Online.